Jonas Berg is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as VP & Head of Rare & Epilepsy Operations for Europe at UCB since May 2013. In this role, Jonas leads a team of 20 professionals, providing strategic and operational support for the epilepsy portfolio across European regions. Previously, Jonas held multiple senior positions at UCB, including VP & Cluster Area Head for a 10-country cluster and Head of Global Payer System Strategy. Earlier roles include General Manager for Grünenthal in the Nordics and various leadership positions at AstraZeneca, focusing on asthma, COPD, and strategy development in China. Jonas holds educational credentials from Lund University and the University of Graz.
This person is not in the org chart
This person is not in any teams
This person is not in any offices